Recent publications
Article
Daley, AJ, Griffin, RA, Moakes, CA, Sanders, JP, Skrybant, M, Ives, N, Maylor, B, Greenfield, SM, Gokal, K, Parretti, HM, Biddle, SJH, Greaves, C, Maddison, R, Mutrie, N, Esliger, DW, Sherar, L, Edwardson, CL, Yates, T, Frew, E, Tearne, S & Jolly, K 2023, 'Snacktivity™ to promote physical activity and reduce future risk of disease in the population: protocol for a feasibility randomised controlled trial and nested qualitative study', Pilot and Feasibility Studies, vol. 9, no. 1, 45. https://doi.org/10.1186/s40814-023-01272-8
PREDNOS Collaborative Group, NIHR Medicines for Children Research Network Nephrology Clinical Studies Group, Afentou, N, Frew, E, Mehta, S, Rowland, N, Woolley, R, Brettell, E, Khan, A, Milford, D, Bockenhauer, D, Saleem , MA, Hall, AS, Koziell, A, Maxwell, H, Hegde , S, Finlay, ER, Gilbert, RD, Jones, C, McKeever, K, Cook, W, Webb, NJA & Christian, MT 2022, 'Economic evaluation of using daily prednisolone versus placebo at the time of an upper respiratory tract infection for the management of children with steroid-sensitive nephrotic syndrome: a model-based analysis', PharmacoEconomics, vol. 6, no. 4, pp. 605-617. https://doi.org/10.1007/s41669-022-00334-6
STOP ACEi Trial Investigators 2022, 'Renin-angiotensin system inhibition in advanced chronic kidney disease', The New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2210639
Kyte, D, Anderson, N, Bishop, J, Bissell, A, Brettell, E, Calvert, M, Chadburn, M, Cockwell, P, Dutton, M, Eddington, H, Forster, E, Hadley, G, Rowland, N, Jackson, L, O’Brien, S, Price, G, Sharpe, K, Stringer, S, Verdi, R, Waters, J & Wilcockson, A 2022, 'Results of a pilot feasibility randomised controlled trial exploring the use of an electronic patient-reported outcome measure in the management of UK patients with advanced chronic kidney disease', BMJ open, vol. 12, no. 3, e050610. https://doi.org/10.1136/bmjopen-2021-050610
RePHILL collaborative group 2022, 'Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial', The Lancet Haematology, vol. 9, no. 4, pp. e250-e261. https://doi.org/10.1016/S2352-3026(22)00040-0
Gokal, K, Amos-Hirst, R, Moakes, C, Sanders, JP, Esliger, DW, Sherar, LB, Ives, N, Biddle, SJH, Edwardson, C, Frew, E, Yates, T, Greaves, C, Rowland, N, Greenfield, S, Jolly, K, Skrybant, M, Maddison, R, Mutrie, N, Parretti, H & Daley, A 2022, 'Views of the public about Snacktivity™: A small changes approach to promoting physical activity and reducing sedentary behaviour', BMC Public Health, vol. 22, no. 618, 618. https://doi.org/10.1186/s12889-022-13050-x
The SUNRRISE Study Group on behalf of the Northwest Research Collaborative and the West Midlands Research Collaborative 2021, 'An international pragmatic randomised controlled trial to compare a single use negative pressure dressing versus a surgeon’s preference of dressing to reduce the incidence of surgical site infection following emergency laparotomy: the SUNRRISE Trial Protocol', Colorectal Disease, vol. 23, no. 4, pp. 989-1000. https://doi.org/10.1111/codi.15474
Edwards, N, Price, A, Mehta, S, Hiemstra, TF, Kaur, A, Greasley , PJ, Webb, DJ, Dhaun, N, MacIntyre, IM, Farrah , T, Melville , V, Herrey , A, Slinn, G, Wale, B, Rowland, N, Wheeler, D, Wilkinson, I, Steeds, R, Ferro, C & Townend, J 2021, 'Effects of spironolactone and chlorthalidone on cardiovascular structure and function in chronic kidney disease', Clinical Journal of the American Society of Nephrology, vol. 16, no. 8, CJN.01930221. https://doi.org/10.2215/CJN.01930221
Christian, M, Webb, NJA, Mehta, S, Woolley, R, Afentou, N, Frew, E, Brettell, E, Khan, A, Milford, D, Bockenhauer, D, Saleem , MA, Hall, AS, Koziell, A, Maxwell, H, Hegde , S, Prajapati , H, Gilbert, RD, Jones, C, McKeever, K, Cook, W & Rowland, N 2021, 'Evaluation of daily low-dose prednisolone during upper respiratory tract infection to prevent relapse in children with relapsing steroid-sensitive nephrotic syndrome: the PREDNOS 2 randomized clinical trial', JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2021.5189
Scobie , S, Jowett, S, Lambe, T, Patel, S, Woolley, R, Rowland, N, Rick, C, Smith, C, Brady , M, Clarke, CE & Sackley, C 2021, 'Lee Silverman voice treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial', Pilot and Feasibility Studies, vol. 7, no. 1, 154. https://doi.org/10.1186/s40814-021-00888-y
Gray, R, Patel, S, Rowland, N, Rick, C, Woolley, R, Muzerengi, S, Gray, A, Jenkinson, C, McIntosh, E, Wheatley, K, Williams, A, Clarke, CE & PD Med Collaborative Group 2021, 'Long-term effectiveness of adjuvant treatment with catechol-O-methyltransferase or monoamine oxidase B inhibitors compared with dopamine agonists among patients with Parkinson disease uncontrolled by Levodopa Therapy: the PD MED randomized clinical trial', JAMA Neurology. https://doi.org/10.1001/jamaneurol.2021.4736
Harper, L, Hewitt, C, Litchfield, I, Morgan, M, Chanouzas, D, Caulfield, H, Coughlan, L, Dean, C, Fletcher, K, Cramp, F, Greenfield, S, Rowland, N, Jowett, S, Kodabuckus, S, Tearne, S, Sehmi, S, Edwardson, C, Dawkins, NP & Daley, A 2021, 'Management of fatigue with physical activity and behavioural change support in vasculitis: a feasibility study', Rheumatology, vol. 60, no. 9, pp. 4130-4140. https://doi.org/10.1093/rheumatology/keaa890
Snacktivity Study Team 2021, '‘Snacktivity™’ to increase physical activity: time to try something different?', Preventive Medicine, vol. 153, 106851. https://doi.org/10.1016/j.ypmed.2021.106851
Markey, K, Mitchell, J, Botfield, H, Ottridge, R, Matthews, T, Krishnan, A, Woolley, R, Westgate, C, Yiangou, A, Alimajstorovic, Z, Shah, P, Rick, C, Ives, N, Taylor, A, Gilligan, L, Jenkinson, C, Arlt, W, Scotton, W, Fairclough, RJ, Singhal, R, Stewart, PM, Tomlinson, JW, Lavery, G, Mollan, S & Sinclair, A 2020, '11β-hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial', Brain Communications, vol. 2, no. 1, fcz050. https://doi.org/10.1093/braincomms/fcz050
Sackley, C, Rick, C, Au, P, Brady , MC, Beaton , G, Burton, C, Caulfield, M, Dickson , S, Dowling, F, Hughes, M, Rowland, N, Jowett, S, Masterson-Algar, P, Nicoll , A, Patel, S, Smith , CH, Woolley, R & Clarke, CE 2020, 'A multi-centre randomised controlled trial to compare the clinical and cost effectiveness of Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial', Trials, vol. 21, no. 1, 436. https://doi.org/10.1186/s13063-020-04354-7
View all publications in research portal